A clinical trials agenda for testing interventions in earlier stages of psychotic disorders

Patrick D. McGorry, Alison R. Yung, Christos Pantelis, Ian B. Hickie

    Research output: Contribution to journalArticlepeer-review

    Abstract

    • A fundamental shift in the design of clinical trials for psychotic disorders is desirable and feasible. Priority should be placed on evaluation of the efficacy of interventions targeting different phases of illness. • A range of traditional therapeutic approaches needs to be augmented by an increased emphasis on the potential benefits of informational, e-health, behavibural and neuroprotective strategies. • A new national clinical trials platform, based on headspace, the National Youth Mental Health Foundation, is outlined. It provides the opportunity for conducting large multisite clinical trials in young people with emerging major mental disorders.
    Original languageEnglish
    Pages (from-to)S33-S36
    JournalMedical Journal of Australia
    Volume190
    Issue number4
    Publication statusPublished - 16 Feb 2009

    Fingerprint

    Dive into the research topics of 'A clinical trials agenda for testing interventions in earlier stages of psychotic disorders'. Together they form a unique fingerprint.

    Cite this